Blood Clot Retrieval Devices Market by Product Type, Distribution Channel, End User 2024-2032
                     Global Blood Clot 
Retrieval Devices Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
Acco r d ing  t o  t h e  l a t es t  r epo r t  b y  I M AR C G r ou p ,  t i t l ed  " B l oo d  C l o t  Re t r i e va l  
Dev i ces  M ark e t :  G l oba l  I ndus t ry  T rend s ,  Sha re ,  S i ze ,  G ro w t h ,  O pp or t u n i t y  and  
For ec as t  20 24 - 2 032 , "  t he  g loba l  b loo d  c lo t  r e t r i ev a l  d ev i ce s  m ar k e t  s i ze  r eac hed  
US$  1 . 4  B i l l i on  i n  202 3 .
Factors  Af fect ing the  Growth of  the Blood Clot  Ret r ieva l  Devices Industry :
Report Technologica l  Advancements  and Innovat ion:
The  c on t i nu ous  a dvanc em en t s  and  i nnova t i on  a r e  im pe l l i ng  t he  m ar k e t  g r ow t h .  
Highlight and Deve lopm e n t s  i n  m e d ica l  t ec hno log y  a r e  l ea d ing  t o  t he  c r ea t i o n  o f  m or e  e f f i c i e n t ,  m in im a l l y  i nv as i ve  ( M I )  dev i c es  t ha t  o f f e r  im pr oved  p a t i en t  o u t com es .  M o r eov e r ,  t he  
i n t r o duc t i on  o f  s t en t  r e t r i e ve r s  a nd  as p i r a t io n  ca t he t e r s  i s  r ev o lu t i o n i z ing  t he  
Description t r ea t m en t  o f  i s che m ic  s t r ok es  a nd  p e r i phe r a l  a r t e r y  d i se ases .  
Thes e  adva ncem en t s  no t  o n l y  enha nce  t h e  e f f ec t i venes s  o f  c l o t  r em ova l  b u t  a l so  
r edu ce  p r o cedu r e  t im e s  and  im p r ove  t he  sa f e t y  p r o f i l e ,  l ea d ing  t o  i nc r eas ed  
adop t i on  r a t es  b y  hea l t hca r e  p r o v ide r s .  I nn ova t io ns  i n  dev i c e  des ig n ,  suc h  as  
im p r oved  na v igab i l i t y  a nd  cap t u r e  e f f i c i ency ,  en ab le  t he  t r ea t m en t  o f  c l o t s  i n  m or e  
cha l l e ng ing  ana t om ic a l  l oc a t i on s .
Ris ing Prevalence of  Card iovascular  Diseases and Stroke:
The  i nc rease  in  t he  p reva lence  o f  ca rd iovascu la r  d iseases  (CVDs)  and s t roke  i s  
d r i v ing  the  demand  fo r  b l ood  c lo t  r e t r i eva l  dev ices .  CVDs,  inc lud ing  hear t  a t t acks  
and  s t r okes ,  a re  the  lead ing  causes  o f  dea th  wor l dw ide .  The inc reas ing  
preva lence o f  r i s k  fac t o r s ,  such  as  hyper tens ion ,  d iabe tes ,  obes i t y ,  and  
Report seden ta ry  l i f es t y l es ,  i s  p rope l l i ng  t he  m arke t  g rowth .  
Th is  r i se  i n  CVD cases  i s  d r i v i ng  the  demand  fo r  e f fec t i ve  and  t im e ly  
Highlight and i n t e rven t i ons ,  i nc lud ing  t h rombec t omy p rocedures  us ing  c lo t  re t r ieva l  dev ices .  As  hea l thcare  sys t ems  and p rov ide rs  a re  focus ing  on  reduc ing  the  m orb id i t y  and  
mor ta l i t y  assoc ia t ed  w i t h  s t r okes  and hear t  a t t acks ,  t he  adopt ion  o f  advanced c lo t  
Description re t r ieva l  t echno log ies  i s  r i s ing .
Heal thcare In f rastructure and Reimbursement  Pol ic ies:
The  expans ion  o f  hea l t hcare  in f ras t ruc tu re  and  f avo rab le  re imbursemen t  po l i c ies  
p lay  a  c ruc ia l  ro le  in  t he  adopt ion  o f  b lood  c lo t  r e t r ieva l  dev ices .  Deve loped 
reg ions  have  we l l - es t ab l i shed  hea l thca re  sys tems w i t h  b road  access  to  advanced 
med ica l  t echno log ies ,  i nc lud ing  th rombec tomy dev ices .  The ava i lab i l i t y  o f  
comprehens ive  insurance cove rage and  suppor t i ve  re imbursemen t  f r am eworks  i n  
t hese  reg ions  encourages  the  adopt ion  o f  i nnova t i ve  med ica l  dev i ces  by  reduc ing  
the  f i nanc ia l  bu rden  on  pa t ien t s  and  hea l thcare  p rov ide rs .
Moreover ,  emerg ing  economies  a re  p rog ress ive ly  improv ing  the i r  hea l thca re  
in f ras t ruc tu re  and  insu rance  po l ic ies  to  p rov ide  be t te r  access  to  advanced  
t rea tments .  Gove rnment  in i t ia t i ves  a imed a t  enhanc ing  s t roke  ca re ,  such  as  
the  es tab l ishmen t  o f  s t roke  ne tworks  and  the  inc lus ion  o f  advanced  
th rombec tomy p rocedures  in  na t iona l  t rea tment  gu ide l ines  a re  ensu r ing  tha t  
pa t ien ts  rece ive  t ime ly  and  e f fec t ive  t rea tmen t .
Report 
Request  for  a  PDF sample  o f  th is  repor t :  
Highlight and h t tps : / /www. imarcgroup .com/b lood-c lo t - re t r ieva l -dev ices-marke t / reques tsamp le
Description
Report Description
Global  Blood Clot  Retr ieval  Devices Market  Trends:
The increas ing awareness among heal thcare  pro fess ionals  and pat ients  about  the benef i ts  o f  ear ly  and 
ef fect ive t reatment  of  s t rokes and card iovascular  inc idents  is  bo ls ter ing the market  growth.  Educat iona l  
programs,  c l in ica l  t r ia ls ,  and market ing ef for ts  by manufacturers  are s igni f icant ly  cont r ibut ing to th is  
heightened awareness.  
Heal thcare profess iona ls  are becoming more knowledgeable about  the advancements in  thrombectomy 
dev ices and the importance o f  rap id in tervent ion in  improv ing pat ient  outcomes.  S imul taneously ,  publ ic  
hea l th  campaigns  and pat ient  advocacy groups are emphasiz ing the s igns of  s t roke and the cr i t ica l  
nature  of  seek ing immediate  care,  which in  turn  dr ives  the demand for  advanced t reatment  opt ions.
View Report  TOC,  Figures and Tables :  
ht tps: / /www. imarcgroup.com/blood-clot-retr ieval-devices-market
Breakup by Stroke Type:
• Ischemic Stroke (Blood Clot)
• Hemorrhagic Stroke (Ruptur ing of Arter ies)
• Transient Ischemic Attack
Breakup by Device Type:
Report • Mechanical  Embolus Removal Devices
Segmentation • Penumbra Blood Clot  Retr ieval Devices
• Stent Retr ievers
• Aspirat ion Device
• Ultrasound Assisted Devices
Breakup by End User:
• Hospita ls
• Diagnost ic Centers
• Clinics
• Ambulatory Surgical  Centers
Breakup by Region:
Report • North America
• Europe
Segmentation • Asia-Pacifi c
• Latin America
• Middle East and Afr ica
• Abbott Laboratories
• AngioDynamics, Inc.
• Argon Medical  Devices, Inc.
Competitive • Boston Scient ifi c Corporation Incorporated
Landscape • Johnson & Johnson
• Medtronic plc
with Key 
• Penumbra Inc.
Players • Stryker Corporation
• Terumo Corporation
How has the global blood clot retrieval devices market 
performed so far, and how will it perform in the coming 
years?
What are the drivers, restraints, and opportunities in the 
global blood clot retrieval devices market?
Key What is the impact of each driver, restraint, and opportunity on the global blood clot retrieval devices market?
Questions 
Answered in What are the key regional markets?
the Report
Which countries represent the most attractive blood clot 
retrieval devices market?
What is the breakup of the market based on the stroke type?
Which is the most attractive stroke type in the blood clot 
retrieval devices market?
What is the breakup of the market based on the device type? 
Which is the most attractive device type in the blood clot 
retrieval devices market?
Key What is the breakup of the market based on the end user?
Questions 
Which is the most attractive end user in the blood clot 
retrieval devices market?
Answered in 
the Report What is the competitive structure of the global blood clot retrieval devices market?
Who are the key players/companies in the global blood clot 
retrieval devices market?
1     P r e f a c e
2  S c o p e  a n d  M e t h o d o l o g y
2 . 1  O b j e c t i v e s  o f  t h e  S t u d y
2 . 2  S t a k e h o l d e r s
2 . 3  D a t a  S o u r c e s
2 . 3 . 1  P r i m a r y  S o u r c e s
2 . 3 . 2  S e c o n d a r y  S o u r c e s
2 . 4  M a r k e t  E s t i m a t i o n
Table of 2 . 4 . 1  B o t t o m - U p  A p p r o a c h2 . 4 . 2  T o p - D o w n  A p p r o a c h
2 . 5  F o r e c a s t i n g  M e t h o d o l o g y
3  E x e c u t i v e  S u m m a r y
4  G l o b a l  B l o o d  C l o t  R e t r i e v a l  D e v i c e s  M a r k e t -  I n t r o d u c t i o n
Contents 4 . 1  O v e r v i e w4 . 2  M a r k e t  D y n a m i c s
4 . 3  I n d u s t r y  T r e n d s
4 . 4  C o m p e t i t i v e  I n t e l l i g e n c e
5  G l o b a l  B l o o d  C l o t  R e t r i e v a l  D e v i c e s  M a r k e t  L a n d s c a p e
5 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
5 . 2  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6  G l o b a l  B l o o d  C l o t  R e t r i e v a l  D e v i c e s  M a r k e t -  B r e a k u p  b y  S t r o k e  T y p e
6 . 1  I s c h e m i c  S t r o k e  ( B l o o d  C l o t )
6 . 1 . 1  O v e r v i e w
6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 1 . 3  M a r k e t  S e g m e n t a t i o n
6 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 2  H e m o r r h a g i c  S t r o k e  ( R u p t u r i n g  o f  A r t e r i e s )
6 . 2 . 1  O v e r v i e w
6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
       
6 . 2 . 3  M a r k e t  S e g m e n t a t i o n
6 . 2 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 3  T r a n s i e n t  I s c h e m i c  A t t a c k
6 . 3 . 1  O v e r v i e w
6 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 3 . 3  M a r k e t  S e g m e n t a t i o n
6 . 3 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 4  A t t r a c t i v e  I n v e s t m e n t  P r o p o s i t i o n  b y  S t r o k e  T y p e
7  G l o b a l  B l o o d  C l o t  R e t r i e v a l  D e v i c e s  M a r k e t  -  B r e a k u p  b y  D e v i c e  
T y p e
7 . 1  M e c h a n i c a l  E m b o l u s  R e m o v a l  D e v i c e s
Table of 7 . 1 . 1  O v e r v i e w7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
7 . 1 . 3  M a r k e t  S e g m e n t a t i o n
7 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
Contents 7 . 2  P e n u m b r a  B l o o d  C l o t  R e t r i e v a l  D e v i c e s7 . 2 . 1  O v e r v i e w
7 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
7 . 2 . 3  M a r k e t  S e g m e n t a t i o n
7 . 2 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7 . 3  S t e n t  R e t r i e v e r s
7 . 3 . 1  O v e r v i e w
7 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
7 . 3 . 3  M a r k e t  S e g m e n t a t i o n
7 . 3 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7 . 4  A s p i r a t i o n  D e v i c e
7 . 4 . 1  O v e r v i e w
7 . 4 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
7 . 4 . 3  M a r k e t  S e g m e n t a t i o n
7 . 4 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / b l o o d - c l o t - re t r i e v a l - d ev i c es - m a r ke
t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: